Large-scale testing (Phase 3)Looking for participantsNCT07621809
What this trial is testing
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Who this might be right for
Sjögren´s Disease
Novartis Pharmaceuticals 570